AbbVie Inc (NYSE:ABBV)

62.29
Delayed Data
As of Apr 17
 -0.30 / -0.48%
Today’s Change
47.72
Today|||52-Week Range
70.76
-4.81%
Year-to-Date
AbbVie's HCV Treatment Granted Priority Review in Japan - Analyst Blog
Apr 16 / Zacks.com
Analysts' Actions -- AbbVie, Freeport-McMoRan, Nielsen and More
Apr 13 / TheStreet.com
3 Drugs Stocks Pushing Industry Growth
Apr 16 / TheStreet.com
Gilead combats wider distribution of cheap drugs from EM
Apr 12 / FT.com
Johnson & Johnson's Earnings: The Good, The Bad and The Ugly
Apr 16 / MotleyFool.com
10 Largest Companies by Market Cap in Biotech
Apr 11 / MotleyFool.com
Healthcare ETFs in Focus Post JNJ Earnings Beat - ETF News And Commentary
Apr 16 / Zacks.com
7 High-Dividend Stocks in Healthcare
Apr 10 / MotleyFool.com
The Best Stock to Invest in Hep C
Apr 16 / MotleyFool.com
Merck's HCV Combo Drug Gets Two Breakthrough Status - Analyst Blog
Apr 09 / Zacks.com
Abbott Labs, Sekisui Medical to Offer Coagulation Tests - Analyst Blog
Apr 15 / Zacks.com
Mylan Proposes to Acquire Perrigo, Sets Both Stocks Soaring - Analyst Blog
Apr 09 / Zacks.com
3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog
Apr 15 / Zacks.com
Bet on M&A Frenzy with These ETFs and Stocks - ETF News And Commentary
Apr 08 / Zacks.com
3 Promising Healthcare Stocks Under $10
Apr 15 / MotleyFool.com
Biosimilar drugs: spot the difference
Apr 08 / FT.com
Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern
Apr 14 / Benzinga
Should AbbVie, Inc. Buy Acadia Pharmaceuticals to Help Fight Parkinson's Disease?
Apr 08 / MotleyFool.com
AbbVie (ABBV) Stock Rises Today on Bullish Analyst Notes
Apr 14 / TheStreet.com
Repros Gets EU Update on Secondary Hypogonadism Drug - Analyst Blog
Apr 07 / Zacks.com
J&J cuts guidance as strong dollar hits sales
Apr 14 / FT.com
3 Events That Could Sink the Biotech Sector This Year
Apr 05 / MotleyFool.com
Gilead Sciences Sparks Analyst Dispute Over Hep C Forecasts
Apr 14 / TheStreet.com
The Safest Biotech Bet on the Market
Apr 04 / MotleyFool.com
Biotech: Making sense of the science
Apr 13 / FT.com
Healthcare sector leads feverish M&A activity
Mar 30 / FT.com
AbbVie (ABBV) Stock Opens Higher, Then Falls Today Following Analyst Upgrade
Apr 13 / TheStreet.com
Drugs companies unite to mine genetic data
Mar 25 / FT.com
First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007
Apr 13 / TheStreet.com
Pharmacyclics chief to receive $3.6bn from takeover
Mar 23 / FT.com
Notable Analyst Rating Changes 4/13: (NFLX) (ABBV) (UNH) Upgraded; (ANR) (PDS) (OMC) ...
Apr 13 / Investing Channel
 

To view my watchlist

Not a member yet?

Sign up now for a free account